Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Nannei

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Vaccine|February 15, 2026
Pathways to economically viable and sustainable vaccine manufacturing in LMICsMatthias Helble, Claudia Nannei, Martin Friede, et al.
Science (New York, N.Y.)|September 13, 2014
Creating a global observatory for health R&DRobert F Terry, José F Salm, Claudia Nannei, et al.
Vaccine|August 18, 2016
The 2015 global production capacity of seasonal and pandemic influenza vaccineKenneth A McLean, Shoshanna Goldin, Claudia Nannei, et al.
Vaccines|November 26, 2025
Sustaining Local Production of Influenza Vaccines: A Global Study of Enabling Factors Among Vaccine ManufacturersChristopher Chadwick, Claudia Nannei, Erin Sparrow, et al.
Vaccine|September 12, 2016
Considerations for sustainable influenza vaccine production in developing countriesClaudia Nannei, Christopher Chadwick, Hiba Fatima, et al.
Vaccines|June 25, 2026
Influenza Vaccine Technology Transfer: A Mixed-Methods Study with Vaccine Manufacturers and Global Experts to Assess Successes, Challenges, and OpportunitiesChristopher Chadwick, Erin Sparrow, Claudia Nannei, et al.
Vaccine|September 21, 2016
Stakeholders' perceptions of 10years of the Global Action Plan for Influenza Vaccines (GAP) - Results from a surveyClaudia Nannei, Shoshanna Goldin, Guido Torelli, et al.
Vaccines|April 27, 2026
Unpacking the mRNA Supply Chain: Challenges and Opportunities for Global HealthAriane de Jesus Lopes de Abreu, Cheleka A M Mpande, Yang Song, et al.
Vaccine|December 17, 2019
Does having a seasonal influenza program facilitate pandemic preparedness? An analysis of vaccine deployment during the 2009 pandemicRachael M Porter, Shoshanna Goldin, Kathryn E Lafond, et al.
Vaccines|February 26, 2025
Investment Opportunities for mRNA Technology in Low- and Middle-Income Countries: Key Findings and Future PerspectivesAriane de Jesus Lopes de Abreu, Cheleka A M Mpande, Matthias Helble, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Vaccine|February 15, 2026
Pathways to economically viable and sustainable vaccine manufacturing in LMICsMatthias Helble, Claudia Nannei, Martin Friede, et al.
Science (New York, N.Y.)|September 13, 2014
Creating a global observatory for health R&DRobert F Terry, José F Salm, Claudia Nannei, et al.
Vaccine|August 18, 2016
The 2015 global production capacity of seasonal and pandemic influenza vaccineKenneth A McLean, Shoshanna Goldin, Claudia Nannei, et al.
Vaccines|November 26, 2025
Sustaining Local Production of Influenza Vaccines: A Global Study of Enabling Factors Among Vaccine ManufacturersChristopher Chadwick, Claudia Nannei, Erin Sparrow, et al.
Vaccine|September 12, 2016
Considerations for sustainable influenza vaccine production in developing countriesClaudia Nannei, Christopher Chadwick, Hiba Fatima, et al.
Vaccines|June 25, 2026
Influenza Vaccine Technology Transfer: A Mixed-Methods Study with Vaccine Manufacturers and Global Experts to Assess Successes, Challenges, and OpportunitiesChristopher Chadwick, Erin Sparrow, Claudia Nannei, et al.
Vaccine|September 21, 2016
Stakeholders' perceptions of 10years of the Global Action Plan for Influenza Vaccines (GAP) - Results from a surveyClaudia Nannei, Shoshanna Goldin, Guido Torelli, et al.
Vaccines|April 27, 2026
Unpacking the mRNA Supply Chain: Challenges and Opportunities for Global HealthAriane de Jesus Lopes de Abreu, Cheleka A M Mpande, Yang Song, et al.
Vaccine|December 17, 2019
Does having a seasonal influenza program facilitate pandemic preparedness? An analysis of vaccine deployment during the 2009 pandemicRachael M Porter, Shoshanna Goldin, Kathryn E Lafond, et al.
Vaccines|February 26, 2025
Investment Opportunities for mRNA Technology in Low- and Middle-Income Countries: Key Findings and Future PerspectivesAriane de Jesus Lopes de Abreu, Cheleka A M Mpande, Matthias Helble, et al.
Pageof 1